Former Chairman of the Scientific Council of the National Sequencing Center (Génoscope, Évry). Winner of the Grand Prize for Medical Research from Inserm (2004) and the Foundation for Medical Research (2012).
Rather than declaring the bankruptcy of French research that we saw shine not so long ago, let's try to understand why France could not play the leading role in the fight to stop this pandemic.
The current health crisis reveals the malaise of French research, pointing to the flaws in its organization, funding, governance and monitoring.
Read also: Covid-19: the crisis reveals the weaknesses of French research
Research has never really interested our governments.
Certainly, certain actions have been undertaken, such as the creation of the National Research Agency in 2005, the Research and Higher Education Evaluation Agency (Aeres) in 2006, transformed into HCERES in 2013, the investments for the future in 2010 and recently the research programming law.
This article is for subscribers only.
You have 86% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in